Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide for Overlapping FD and IBS-C
NCT05134584Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Jan 2021
- Primary completion
- Dec 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of linaclotide in functional dyspepsia (FD), irritable bowel syndrome (IBS), sponsored by Renji Hospital. Status: unknown.
02
Drugs
linaclotide
03
Conditions
functional dyspepsia (FD)irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT05134584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05134584.